These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3113256)
41. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies. Narayanan RB; Bhutani LK; Sharma AK; Nath I Clin Exp Immunol; 1983 Mar; 51(3):421-9. PubMed ID: 6342880 [TBL] [Abstract][Full Text] [Related]
42. Tumor necrosis factor enhances interferon-induced Ia antigen expression on murine islet parenchymal cells. Wright JR; Epstein HR; Hauptfeld V; Lacy PE Am J Pathol; 1988 Mar; 130(3):427-30. PubMed ID: 3126660 [TBL] [Abstract][Full Text] [Related]
43. Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally. Fertsch-Ruggio D; Schoenberg DR; Vogel SN J Immunol; 1988 Sep; 141(5):1582-9. PubMed ID: 2457621 [TBL] [Abstract][Full Text] [Related]
44. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Rhodes J; Ivanyi J; Cozens P Eur J Immunol; 1986 Apr; 16(4):370-5. PubMed ID: 2422040 [TBL] [Abstract][Full Text] [Related]
45. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma. Black CM; Catterall JR; Remington JS J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846 [TBL] [Abstract][Full Text] [Related]
46. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Scheynius A; Klareskog L; Forsum U Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638 [TBL] [Abstract][Full Text] [Related]
47. Recent advances in cytokine therapy in leprosy. Kaplan G J Infect Dis; 1993 Mar; 167 Suppl 1():S18-22. PubMed ID: 8433015 [TBL] [Abstract][Full Text] [Related]
48. Correlation between the inducible keratinocyte expression of Ia and the movement of Langerhans cells into the epidermis. Roberts LK; Krueger GG; Daynes RA J Immunol; 1985 Jun; 134(6):3781-4. PubMed ID: 2580896 [TBL] [Abstract][Full Text] [Related]
49. Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan. Becker S J Immunol; 1984 Mar; 132(3):1249-54. PubMed ID: 6420462 [TBL] [Abstract][Full Text] [Related]
50. Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are mediated by changes in steady-state levels of Ia mRNA. Fertsch D; Schoenberg DR; Germain RN; Tou JY; Vogel SN J Immunol; 1987 Jul; 139(1):244-9. PubMed ID: 3108400 [TBL] [Abstract][Full Text] [Related]
51. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000 [TBL] [Abstract][Full Text] [Related]
52. MHC class II antigen expression is not induced on murine epidermal keratinocytes by interferon-gamma alone or in combination with tumour necrosis factor-alpha. Yeoman H; Anderton JG; Stanley MA Immunology; 1989 Jan; 66(1):100-5. PubMed ID: 15493270 [TBL] [Abstract][Full Text] [Related]
53. Interferon-gamma in vivo. Induction and loss of class II MHC antigens and immature myelomonocytic cells in rat organs. Steiniger B; Falk P; Van der Meide PH Eur J Immunol; 1988 May; 18(5):661-9. PubMed ID: 3132395 [TBL] [Abstract][Full Text] [Related]
54. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. Masuyama J; Minato N; Kano S J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562 [TBL] [Abstract][Full Text] [Related]
55. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738 [TBL] [Abstract][Full Text] [Related]
56. Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. Hancock WW; Khoury SJ; Carpenter CB; Sayegh MH Am J Pathol; 1994 Jun; 144(6):1149-58. PubMed ID: 8203456 [TBL] [Abstract][Full Text] [Related]
57. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
58. Interleukins 18 and 12 synergistically upregulate interferon-gamma production by murine dendritic epidermal T cells. Sugaya M; Nakamura K; Tamaki K J Invest Dermatol; 1999 Sep; 113(3):350-4. PubMed ID: 10469333 [TBL] [Abstract][Full Text] [Related]
59. T lymphocyte subsets in the skin lesions of patients with leprosy. Modlin RL; Hofman FM; Taylor CR; Rea TH J Am Acad Dermatol; 1983 Feb; 8(2):182-9. PubMed ID: 6219136 [TBL] [Abstract][Full Text] [Related]